DE1195306B - Process for the preparation of a 3-methyl-7-keto-8- (3'-ketobutyl) -3, 4- [3'-acyloxy-cyclo-pentano- (2 ', 1')] decahydronaphthalene compound - Google Patents
Process for the preparation of a 3-methyl-7-keto-8- (3'-ketobutyl) -3, 4- [3'-acyloxy-cyclo-pentano- (2 ', 1')] decahydronaphthalene compoundInfo
- Publication number
- DE1195306B DE1195306B DEL40409A DEL0040409A DE1195306B DE 1195306 B DE1195306 B DE 1195306B DE L40409 A DEL40409 A DE L40409A DE L0040409 A DEL0040409 A DE L0040409A DE 1195306 B DE1195306 B DE 1195306B
- Authority
- DE
- Germany
- Prior art keywords
- ketobutyl
- keto
- methyl
- acyloxy
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/385—Saturated compounds containing a keto group being part of a ring
- C07C49/487—Saturated compounds containing a keto group being part of a ring containing hydroxy groups
- C07C49/507—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
BUNDESREPUBLIK DEUTSCHLAND FEDERAL REPUBLIC OF GERMANY
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
AUSLEGESCHRIFTEDITORIAL
Int. Cl.:Int. Cl .:
C07cC07c
Deutsche KL: 12 ο-25/04 German KL: 12 ο -25/04
Nummer: 1195 306Number: 1195 306
Aktenzeichen: L 40409IV b/12 οFile number: L 40409IV b / 12 ο
Anmeldetag: 7. November 1961Filing date: November 7, 1961
Auslegetag: 24. Juni 1965Opening day: June 24, 1965
Das Hauptpatent 1 142 603 betrifft ein Verfahren, welches darin besteht, daß man eine Zl8-3-Methyl-7-keto-8-(3"-ketobutyl)-3,4, - ß'-acyloxy-cyclopentano-(2',l')]-octahydronaphthalinverbindung der allgemeinen Formel IThe main patent 1 142 603 relates to a process which consists in the fact that a Zl 8 -3-methyl-7-keto-8- (3 "-ketobutyl) -3,4, - ß'-acyloxy-cyclopentano- (2nd ', l')] - octahydronaphthalene compound of the general formula I.
OAcOAc
worin Ac den Rest einer niederen aliphatischen oder einer aromatischen Carbonsäure bedeutet, katalytisch hydriert, wobei man die entsprechende 3-Methyl-7-keto-8-(3"-ketobutyl)-3,4-[3'-acyloxy-cyclopentanoso (2',r)]-decahydronaphthalinverbindung der Formelllwhere Ac is the residue of a lower aliphatic or an aromatic carboxylic acid, catalytic hydrogenated, the corresponding 3-methyl-7-keto-8- (3 "-ketobutyl) -3,4- [3'-acyloxy-cyclopentanoso (2 ', r)] - decahydronaphthalene compound of the formula
OAcOAc
erhält, die auch als Sß
4,5-seco-androstan bezeichnet werden kann. Gemäß Hauptpatent wird die letztere Verbindung anschließend
mit Hilfe von Dehydratisierungsmitteln zu 19-nor-Testosteron cyclisiert.receives, which is also called sweet
4,5-seco-androstane can be designated. According to the main patent, the latter compound is then cyclized to 19-nor-testosterone with the aid of dehydrating agents.
Nach dem Verfahren des genannten Hauptpatents, wird die katalytische Hydrierung der Doppelbindung in 8(9)-Stellung der Verbindung I auf herkömmliche Weise, d. h. in neutralem Milieu, durchgeführt, wobei ein farbloses Harz erhalten wird, das, wie nachträglich festgestellt worden ist, zum größten Teil aus einem Gemisch von etwa gleichen Mengen der beiden [9a, 10a H]- und [9ß, 100 H]-Isomeren des 3,5-Dioxo-17/9-acyloxy-19-nor-4,5-seco-androstans besteht, von denen lediglich das [9<x, 10« H]-Isomere durch Cyclisierung das 19-nor-Testosteron natürlicher Konfiguration liefert.According to the process of the cited main patent, the catalytic hydrogenation of the double bond in the 8 (9) position of the compound I is carried out in a conventional manner, that is to say in a neutral medium, a colorless resin being obtained which, as has subsequently been determined, for mostly from a mixture of approximately equal amounts of the two [9a, 10a H] and [9ß, 100 H] isomers of 3,5-dioxo-17/9-acyloxy-19-nor-4,5-seco- androstans, of which only the [9 <x, 10 «H] isomer provides the 19-nor-testosterone of natural configuration by cyclization.
Die vorliegende Erfindung betrifft eine Verbesserung der Hydrierungsstufe des Verfahrens des Hauptpatents die darin besteht, daß man die katalytische Hydrierung Verfahren zur Herstellung einer 3-Methyl-The present invention relates to an improvement in the hydrogenation stage of the process of the main patent which consists in the fact that the catalytic hydrogenation process for the preparation of a 3-methyl-
7-keto-8-(3"-ketobutyl)-3,4-[3'-acyloxy-cyclo-7-keto-8- (3 "-ketobutyl) -3,4- [3'-acyloxy-cyclo-
pentano-(2',l')]-decahydronaphthalmverbindungpentano (2 ', l')] decahydronaphthalm compound
Zusatz zum Patent: 1142 603Addendum to the patent: 1142 603
Anmelder:
Roussel-Uclaf, ParisApplicant:
Roussel-Uclaf, Paris
Vertreter:Representative:
Dr. F. Zumstein,Dr. F. Zumstein,
Dipl.-Chem. Dr. rer. nat. E. AssmannDipl.-Chem. Dr. rer. nat. E. Assmann
und Dipl.-Chem. Dr. R. Koenigsberger,and Dipl.-Chem. Dr. R. Koenigsberger,
Patentanwälte, München 2, Bräuhausstr. 4Patent Attorneys, Munich 2, Bräuhausstr. 4th
Als Erfinder benannt:Named as inventor:
Dr.-Ing. Gerard Nomine, Noisy-le-Sec, Seine;
Dr. Robert Bucourt, Villiers-le-Bel, Seine-et-Oise;
Andre Pierdet, Noisy-le-Sec, Seine (Frankreich)Dr.-Ing. Gerard Nomine, Noisy-le-Sec, Seine;
Dr. Robert Bucourt, Villiers-le-Bel, Seine-et-Oise; Andre Pierdet, Noisy-le-Sec, Seine (France)
Beanspruchte Priorität:Claimed priority:
Frankreich vom 16. November 1960 (844101)France of November 16, 1960 (844101)
der Doppelbindung in 8(9)-Stellung der Verbindung I in einem basischen Milieu, insbesondere bei einem pH-Wert um 11, in Gegenwart eines Katalysators auf der Basis von Palladiumhydroxyd durchführt.the double bond in the 8 (9) position of the compound I in a basic medium, in particular in a pH around 11, in the presence of a catalyst based on palladium hydroxide.
Nach einer besonderen Ausführungsform des erfindungsgemäßen Verfahrens wird die Basizität des Reaktionsmilieus durch Zugabe von Triäthylamin bewirkt.According to a particular embodiment of the invention In the process, the basicity of the reaction medium is made by adding triethylamine causes.
Durch die erfindungsgemäße Abänderung des Verfahrens des Hauptpatents verläuft die Hydrierung stereospezifisch, und die Ausbeute an dem gewünschten [9a, 10a H]-Isomeren wird beträchtlich erhöht.As a result of the inventive modification of the process of the main patent, the hydrogenation takes place stereospecific, and the yield of the desired [9a, 10a H] isomer is increased considerably.
Das neue Verfahren ergibt unter Verwendung der Ausgangsverbindung I, worin Ac = C6H5CO bedeutet, eine Ausbeute von 95°/o an reinem 3,5-Dioxo-17/J-benzoyloxy-[9a,10a H]-19-nor-4,5-seco-androstan, das leicht kristallisierbar ist.The new process results in using the starting compound I in which Ac represents = C 6 H 5 CO, a yield of 95 ° / o of pure 3,5-dioxo-17 / J-benzoyloxy [9a, 10a H] -19- nor-4,5-seco-androstane, which is easy to crystallize.
509 597/427509 597/427
Das folgende Beispiel dient zur näheren Erläuterung des erfindungsgemäßen Verfahrens.The following example serves to explain the process according to the invention in more detail.
Herstellung von 3-Methyl-7-keto-8-(3"-ketobutyl)-Production of 3-methyl-7-keto-8- (3 "-ketobutyl) -
3,4-[3'-benzoyloxy-cyclopentano-(2',r)]-decahydro-3,4- [3'-benzoyloxy-cyclopentano- (2 ', r)] - decahydro-
naphthalin (Verbindung II, Ac = C8H5CO)naphthalene (compound II, Ac = C 8 H 5 CO)
Man löst 550 mg J8-3-Methyl-7-keto-8-(3"-ketobutyl)-3,4-[3'-benzoyloxy-cyclopentano-(2', l')]-octahydronaphthalin (Verbindung I, Ac = C6H5CO) vom F. = 117°C, [«]£ = + 43° (c = 1 % Methanol), das, wie im Hauptpatent 1 142 603 beschrieben, erhalten wurde, in 40 ecm 950ZoIg6D1 Äthanol. Die Lösung wird zu einer Suspension von 40 mg Palladium-Kohle, die 15% Palladiumhydroxyd enthält, in 5 ecm Alkohol gefügt. Dann gibt man eine 10%ige alkoholische Triäthylaminlösung zu, bis der pH-Wert 11 erreicht ist; anschließend rührt man unter Wasserstoifatmosphäre IVs Stunden. Man filtriert, dampft das Filtrat im Vakuum zur Trockne ein und kristallisiert den Rückstand aus Isopropyläther. Ausbeute: 431 mg (etwa 78 %) an 3-Methyl-7-keto-8-(3"-ketobutyl)-3,4-[3'-benzoyloxy - cyclopentano - (2', I1)] - decahydronaphthalin vom augenblicklichen F. = 1140C. [«]!? = + 48° (c = 1 % Methanol). Aus der Mutterlauge kann man noch 17% des identischen Produktes gewinnen. Das Produkt ergibt sich in Form farbloser Nadeln, die in Methanol und Äthanol löslich und in Wasser und verdünnten wäßrigen Säuren und Alkalien unlöslich sind.550 mg of I 8 -3-methyl-7-keto-8- (3 "-ketobutyl) -3,4- [3'-benzoyloxy-cyclopentano- (2 ', l')] - octahydronaphthalene (compound I, Ac = C 6 H 5 CO), mp = 117 ° C, [ «] £ = + 43 ° (c = 1% methanol) which was obtained as described in the main Patent 1,142,603, in 40 cc of 95 0 ZoIg 6 D 1 Ethanol The solution is added to a suspension of 40 mg palladium-carbon, which contains 15% palladium hydroxide, in 5 cm alcohol.Then a 10% alcoholic triethylamine solution is added until the pH value 11 is reached The mixture is then stirred under a hydrogen atmosphere for IVs hours. It is filtered, the filtrate is evaporated to dryness in vacuo and the residue is crystallized from isopropyl ether. Yield: 431 mg (about 78%) of 3-methyl-7-keto-8- (3 " -ketobutyl) -3,4- [3'-benzoyloxy - cyclopentano - (2 ', I 1 )] - decahydronaphthalene of the current F. = 114 0 C. [«] !? = + 48 ° (c = 1% methanol). 17% of the identical product can still be obtained from the mother liquor. The product results in the form of colorless needles which are soluble in methanol and ethanol and insoluble in water and dilute aqueous acids and alkalis.
Analyse: Cg6H88O4 = 396,5
Berechnet ... C 75,72%, H 8,13 %;
gefunden ... C75,7%, H8,2%.Analysis: Cg 6 H 88 O 4 = 396.5
Calculated ... C 75.72%, H 8.13%;
found ... C75.7%, H8.2%.
UV-Spektrum in Äthanol:UV spectrum in ethanol:
ληαχ. = 230 πιμ, s == 14 300,
Xg111x- = 273 ΐημ, β = 940,
haax. = 280 ηαμ, e = 765. ληαχ. = 230 πιμ, s == 14 300,
Xg 111x- = 273 ΐημ, β = 940,
haax. = 280 ηαμ, e = 765.
Rotationsdispersion:Rotary dispersion:
[Ml400 = + 190[Ml 400 = +190
[M]317 = — 3480 (Minimum)[M] 317 = - 3480 (minimum)
[M]300=+ 290[M] 300 = + 290
[M]350=- 245[M] 350 = - 245
[M]309 = - 2650 (Inflexion)[M] 309 = - 2650 (inflexion)
[M]287 = 4880 (Spitze)[M] 287 = 4880 (peak)
Claims (2)
Angewandte Chemie, Bd. 72 (1960), S. 728.Considered publications:
Angewandte Chemie, Vol. 72 (1960), p. 728.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1195306X | 1960-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1195306B true DE1195306B (en) | 1965-06-24 |
Family
ID=9668628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DEL40409A Pending DE1195306B (en) | 1960-11-16 | 1961-11-07 | Process for the preparation of a 3-methyl-7-keto-8- (3'-ketobutyl) -3, 4- [3'-acyloxy-cyclo-pentano- (2 ', 1')] decahydronaphthalene compound |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE1195306B (en) |
-
1961
- 1961-11-07 DE DEL40409A patent/DE1195306B/en active Pending
Non-Patent Citations (1)
Title |
---|
None * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1163850B (en) | Process for the production of new, non-ionic, skin-friendly derivatives of capillary-active tertiary amines | |
DE2923949C2 (en) | Process for the production of 1,4-butanediol by catalytic hydrogenation of 1,4-butynediol | |
DE1168892B (en) | Method for purifying butyne- (2) -diol- (1, 4) | |
DE1793732B2 (en) | PROCESS FOR THE MANUFACTURING OF 17 (ACYLOXY OR ALKOXY) -POLYUNESATIGATED GONANES OR 8-ISOGONAN DERIVATIVES | |
DE1227914B (en) | Process for the preparation of 3- (1, 2-dithia-cyclopentyl) -5-pentanoic acid | |
DE1228254B (en) | Process for the production of antibacterially active dihydrofusidic acid or salts | |
DE1195306B (en) | Process for the preparation of a 3-methyl-7-keto-8- (3'-ketobutyl) -3, 4- [3'-acyloxy-cyclo-pentano- (2 ', 1')] decahydronaphthalene compound | |
DE1221388B (en) | Fragrance composition | |
DE1943440A1 (en) | New prostaglandin derivatives | |
DE2652165A1 (en) | PROCESS FOR THE PRODUCTION OF VINCAMIN AND EPI-VINCAMIN FROM (-) TABERSONINE | |
DE877613C (en) | Process for the preparation of alkyl derivatives of ª‰-[2-oxynaphthyl-(6)]-propionic acid with ovarian hormone activity | |
DE2721766C2 (en) | ||
DE520939C (en) | Process for the preparation of allyl alcohol | |
DE2328605C2 (en) | Process for the preparation of a mixture of diastereoisomers of zearalanol | |
AT144989B (en) | Process for the preparation of hydrogenation products of the follicular hormone. | |
DE2111606A1 (en) | Process for the preparation of a mixture of diastereoisomers from zearalanol | |
DE929969C (en) | Process for the catalytic hydrogenation of organic compounds | |
DE1518281A1 (en) | Process for the production of fragrances of the ambratype | |
DE900938C (en) | Process for the preparation of 1- (o-oxyphenyl) -1-oxy-2-aralkylamino-propanes | |
AT226707B (en) | Process for the preparation of new 11b-benzo- (a) -quinolizine derivatives | |
DE1002337C2 (en) | Process for the preparation of hydrophenanthrylcarboxylic acids | |
DE733808C (en) | Process for the production of hormone-active substances | |
DE931770C (en) | Process for the preparation of 17-oxypregnen- (5) -ol- (3) -one- (20) | |
DE1158506B (en) | Process for the production of new therapeutically effective 16-methylene steroid-3-enolethers of the pregnan series | |
DE1134986B (en) | Process for the production of cyclic 16 alpha, 17 alpha acetals and ketals of the 6 alpha-methylpregnane series. |